Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aluminum Chloride for Residual Limb Hyperhidrosis
NCT03416348Phase 1Completed
- Sponsor
- University of Utah
- Start
- May 2018
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in hyperhidrosis comparing Placebo Comparator AIM 1 with Aluminum Chloride vs Placebo in Amputees (2 arms). Primary endpoint: Hyperhidrosis Disease Severity Scale at 1 day. Started May 2018; status: completed.
02
Drugs
aluminum chloride
03
Conditions
hyperhidrosis
Beyond the preview
Go deeper on NCT03416348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03416348.